Welcome, Guest |
TOPIC:
AbbVie's Mavyret Approved 6 years 8 months ago #25109
Official price for eight weeks is set at US$26,400. Mavyret is a combo of an NS3/4a inhibitor, Glecaprevir, and an NS5A inhibitor, Pibrentasvir. Seattle Times: www.seattletimes.com/business/fda-oks-ne...orms-of-hepatitis-c/ Fierce Pharma: www.fiercepharma.com/pharma/abbvie-s-new...ndercuts-competition ABC: abcnews.go.com/Health/wireStory/fda-oks-...s-hepatitis-49019076 | |
AbbVie's Mavyret Approved 6 years 6 months ago #25346
Further on this, AbbVie have also announced approval for treatment of all genotypes in Japan has been granted. news.abbvie.com/news/press-releases/abbv...s-gt1-6-in-japan.htm | |
Time to create page: 0.063 seconds